About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

Scancell to produce and clinically validate T cell redirecting bispecific antibodies

Krystal Biotech looks for FDA approval for dystrophic epidermolysis bullosa treatment

Gemelli Biotech to work on gastrointestinal diseases with new $19M funding

BRIM Biotechnology enters OTC trading in Taiwan

Rensselaer researchers make face masks to fight viruses

Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M funding

ADVERTISEMENT

From mugwort allergy to an effective vaccine?

Galapagos to acquire CellPoint and AboundBio to advance cell therapies

Therorna funding to accelerate circRNA-based platform

Elypta raises $21M to develop early detection test for all cancers

Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies

Biotalys and Novozymes partner on biofungicide

ADVERTISEMENT